‘India
has highly qualified clinicians providing excellent clinical care’
Dr Ravi Anand, MD, a resident of Switzerland, an independent consultant
specialises in the development and commercialisation of New Chemical
Entities (NCE) for Central Nervous System (CNS) disorders. He is a
consultant to pharmaceutical and biotech companies, contract research
organisations (CROs), universities and financial institutions. Dr
Anand in an exclusive with N V Ramamurthy discusses various issues
in clinical trials. Excerpts:
|
